OM (Outset Medical, Inc. Common Stock) Stock Analysis - News
Outset Medical, Inc. Common Stock (OM) is a publicly traded Healthcare sector company. As of May 21, 2026, OM trades at $4.34 with a market cap of $68.96M and a P/E ratio of -1.04. OM moved +13.73% today. Year to date, OM is +15.26%; over the trailing twelve months it is -77.55%. Its 52-week range spans $3.00 to $25.35. Analyst consensus is strong buy with an average price target of $9.50. Rallies surfaces OM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in OM news today?
Outset Medical Q1 Revenue Drops 6% to $27.9M, Gross Margin Rises to 43.4%: Outset Medical’s first-quarter net revenue was $27.9 million, down 6% year-over-year, while recurring consumables and services revenue held steady at $22.5 million. Gross margin expanded over 600 basis points to 43.4%, net loss narrowed to $19 million and cash plus equivalents reached $161 million.
Outset Medical Q1 Revenue Drops 6% to $27.9M, Gross Margin Rises to 43.4%: Outset Medical’s first-quarter net revenue was $27.9 million, down 6% year-over-year, while recurring consumables and services revenue held steady at $22.5 million. Gross margin expanded over 600 basis points to 43.4%, net loss narrowed to $19 million and cash plus equivalents reached $161 million.
Does Rallies summarize OM news?
Yes. Rallies summarizes OM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is OM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.
